Melissa Bent

Associate Professor of Clinical Orthopaedic Surgery

Image of Melissa Bent
Is this your profile? Click to edit

Overview

Dr. Bent is an assistant professor of clinical orthopedic surgery. She trained in pediatrics at the University of California, San Francisco and then completed a fellowship in non operative pediatric orthopedics at the University of Wisconsin-Madison. She is a co-director and site principal investigator of the Consortium of Technology in Pediatrics (CTIP 3.0), an FDA funded pediatric medical device accelerator with Drs. Yaniv Bar Cohen and Juan Espinoza at Lurie Children’s Hospital. She currently focuses on the use of augmented reality in pediatric rehabilitation in children with cerebral palsy. Melissa’s other academic interests include health equity in orthopedics and rehabilitation, pediatric medical device and techequity, clubfoot clinical outcomes, and advancing the growing field of non operative pediatric orthopedics.

Research Funding

  • The Use of Exergaming with augmented reality (AR) to promote physical activity in children with Cerebral Palsy
    SC-CTSI (NIH/NCATS) · Apr 1, 2023 – Mar 31, 2026 · Role: Principal Investigator

Research Keywords

  • Pediatric rehabilitation
  • Clubfoot
  • Health equity

Publications

  • The diagnosis and management of common childhood orthopedic disorders: An update. Curr Probl Pediatr Adolesc Health Care. 2020 10; 50(10):100884.. View in PubMed
  • Relationships among classifications of impairment and measures of ambulatory function for children with spina bifida. Disabil Rehabil. 2021 12; 43(25):3696-3700.. View in PubMed
  • The prevalence and risk factors for foot pressure ulcers in ambulatory pediatric patients with spina bifida. Disabil Rehabil. 2021 05; 43(9):1287-1291.. View in PubMed
  • A Pilot Study on Resident and Pediatrician Knowledge and Confidence in the Diagnosis of Slipped Capital Femoral Epiphysis. Glob Pediatr Health. 2019; 6:2333794X19862127.. View in PubMed
  • Clinical Characteristics and Outcomes of Pediatric Patients with Desmoplastic Small Round Cell Tumor. Rare Tumors. 2016 Mar 21; 8(1):6145.. View in PubMed
  • Phase I/II study of (131)I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma. Br J Cancer. 2015 Feb 17; 112(4):644-9.. View in PubMed